Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin testing to predict peri-operative anaphylaxis to neuromuscular blocking drugs
2005-001622-91Phase 4Unknown
- Sponsor
- Royal Group Hospitals
- Start
- May 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of rocuronium, vecuronium, atracurium and cisatracurium in Perioperative anaphylaxis, drug allergy and Chlorhexidine allergy, sponsored by Royal Group Hospitals. Primary endpoint: Primary. Status: unknown.
02
Drugs
rocuroniumvecuroniumatracuriumcisatracurium
03
Conditions
Perioperative anaphylaxisdrug allergyChlorhexidine allergy
Beyond the preview
Go deeper on 2005-001622-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001622-91.